Abbott Laboratories (ABT) Gross Margin (2009 - 2026)
Abbott Laboratories (ABT) posted Gross Margin of 57.71% for Q2 2026, up 2.7% sequentially from 56.2% in Q1 2026, and up 128.0% YoY from 25.31% in Q2 2025.
Abbott Laboratories (ABT) Gross Margin (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported Gross Margin for 18 years, with the latest figure at 57.71% in Q2 2026.
- Quarterly Gross Margin rose 128.0% year-over-year to 57.71% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 56.61% (up 60.0% YoY) and the FY2025 annual result came in at 56.42%, up 101.0% from the prior year.
- Gross Margin improved to 57.71% in Q2 2026 per ABT's latest filing, from 56.2% in the prior quarter.
- Over five years, Gross Margin peaked at 58.07% in Q1 2022 and troughed at 54.48% in Q4 2022.
- A 5-year average of 55.9% and a median of 55.6% in 2024 frame the typical range for Gross Margin.
- The widest YoY moves for Gross Margin: up 457 bps in 2022, down 399 bps in 2022.
- Over 5 years, Gross Margin stood at 54.48% in 2022, then grew by 2 bps to 55.51% in 2023, then dropped by 1 bps to 54.97% in 2024, then grew by 4 bps to 57.05% in 2025, then grew by 1 bps to 57.71% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 57.71%, 56.2%, and 57.05% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|